Effects of smoking cessation on insulin and cardiovascular risk factors - A controlled study of 4 months' duration

Journal of Internal Medicine

Volumn 240, Issue 4, 1996, Pages 189-194

  Nilsson, P ^a   Lundgren, H ^b   Soderstrom M ^a   Fagerstrom K O ^c   Nilsson Ehle, P ^d  

^a LUND UNIVERSITY   (Sweden)

^b Health Centre   (Sweden)

^c PFIZER INC   (United States)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C peptide; Fibrinogen; Glucose; Insulin; Lipoprotein; Smoking cessation

Indexed keywords

C PEPTIDE; FIBRINOGEN; GLUCOSE; INSULIN; LIPID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION;

EID: 0029950408     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.16844000.x     Document Type: Article

References (38)

1. Mancia G, Fitzgerald GA, eds. Smoking : a risk factor for cardiovascular disease. Am Heart J 1988; 115 (Suppl. 1. Part 2): 239-96.
2. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988; 259: 1025-9.
3. Fielding JE. Smoking, health effects and control. N Engl J Med 1985; 313: 555-61.
4. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989; 298: 784-8.
5. Axelsen M, Eliasson B, Joheim E, Lenner RA, Taskinen M-R, Smith U. Lipid intolerance in smokers. J Intern Med 1995; 237: 449-55.
6. Zavaroni I, Bonini L, Gasparini P, Dall'Aglio E, Passeri M, Reaven GM. Cigarette smokers are relatively glucose intolerant, hyperinsulinemic and dyslipidemic. Am J Cardiol 1994; 73: 904-5.
7. Facchini FS, Hollenbeck CB, Jeppesen J, Chen I, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-30.
8. Attvall S, Fowelin J, Lager I, von Schenk H, Smith U. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J Intern Med 1993; 233: 327-32.
9. Eliasson B, Attvall S, Taskinen M-R, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 1994; 14: 1946-50.
10. Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Cirrulation 1987; 76: 6-14.
11. Yarnell JWG. Smoking and haemostatic risk factors. Cardiovasc Risk Factors 1993; 3: 222-7.
12. Puska P, Salonen JT, Nissinen A, Tuomilehto J, Vartiainen E, Korhonen K, et al. Change in risk factors for coronary heart disease during ten years of community intervention programmes. BMJ 1983; 287: 1840-4.
13. Hjermann I, Byre KV, Holme I, Leren P. Report from the Oslo Study Group of a randomised trial in healthy men. Effects of diet and smoking intervention on the incidence of coronary heart disease. Lancet 1981; ii: 1303-10.
14. MRFIT Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypothesis of the trial. JAMA 1990; 263: 1795-801.
15. Stubbe I, Eskilsson J, Nilsson-Ehle P. High-density lipoprotein concentrations increase after stopping smoking. BMJ 1982; 284: 1511-5.
16. Rabkin SW. Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. A controlled clinical trial. Atherosclerosis 1984; 53: 173-84.
17. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991; 324: 739-45.
18. Moffatt RJ, Owens SG. Cessation from smoking: Changes in body weight, body composition, resting metabolism, and energy consumption. Metabolism 1991; 40: 465-70.
19. Quensel M, Söderström A, Agardh CD, Nilsson-Ehle P. High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet. Atherosclerosis 1989; 75: 189-93.
20. Russell MA, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, et al. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ 1993; 306: 1 308-12.
21. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139-42.
22. Report from a WHO Study Group. Diabetes mellitus. WHO Technical Report Series, World Health Organization, Geneva, 1985; No. 727.
23. Haggard HW, Greenberg LA. The effects of cigarette smoking upon blood sugar. Science 1934; 79: 165-6.
24. Hellerstein MK, Benowitz NL, Neese RA, Schwartz J-M, Hoh R, Jacob P, et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994; 93: 265-72.
25. Hanson M, Almér L-O, Ekman R, Janzon L, Trell E. Motilin response to a glucose load aberrant in smokers. Scand J. Gastronterol 1987; 22: 809-12.
26. Johnson RD, Horowitz M, Maddox AF, Wishart JM, Shearman DJ. Cigarette smoking and rate of gastric emptying: effect on alcohol absorption. BMJ 1991; 302: 20-3.
27. Janzon L, Berntorp K, Hanson M, Lindell S-E, Trell E. Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia 1983; 25: 86-8.
28. Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated haemoglobin A1C distribution in a healthy population. The TELECOM study. Diabetologia 1989; 32: 864-9.
29. 1 levels in normal glucose tolerance. Diabetes Care 1988; 11: 422-8.
30. 1C, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers compared to non-smokers. Metabolism 1995; 44: 557-61.
31. Quensel M, Agardh CD, Nilsson-Ehle P. Nicotine does not effect plasma lipoprotein concentrations in healthy men. Scand J Clin Lab Invest 1989; 49: 149-53.
32. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; ii: 986-8.
33. Lee AJ, Smith WC, Lowe GO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: The Scottish Heart Health study. J Clin Epidemiol 1990; 43: 913-6.
34. Eliasson M, Asplund K, Evrin P-E, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, tibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 1995; 113: 41-53.
35. Green MS, Jucha E, Luz Y. Blood pressure in smokers and non-smokers: epidemiological findings. Am Heart J 1986; 111: 932-40.
36. Benowitz NL, Sharp DS. Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation 1989; 80: 1309-12.
37. Green MS, Harari G, Schwartz K. Cigarette smoking related to ambulatory blood pressure and heart rate. Am Heart J 1991; 121: 1569-70.
38. Hansen KW, Pedersen MN, Christensen JS, Mogensen CE. Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. Blood Pressure 1994; 3: 581-8.